Drug Shortage Report for MICRO PLUS 6 (PEDIATRIC)

Last updated on 2023-08-15 History
Report ID 178549
Drug Identification Number 02091100
Brand name MICRO PLUS 6 (PEDIATRIC)
Common or Proper name MICRO PLUS 6 (PEDIATRIC)
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) IODINE SELENIUM CHROMIUM MANGANESE COPPER ZINC
Strength(s) 60MCG 20MCG 4MCG 0.1MG 0.4MG 3MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-07
Estimated end date 2023-08-11
Actual end date 2023-08-14
Shortage status Resolved
Updated date 2023-08-15
Company comments Baxter item: 5050. Product is available on allocation based on 50% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2023-08-15 English Compare
v17 2023-08-14 French Compare
v16 2023-08-14 English Compare
v15 2023-02-16 French Compare
v14 2023-02-16 English Compare
v13 2023-02-16 French Compare
v12 2023-02-16 English Compare
v11 2023-01-27 French Compare
v10 2023-01-27 English Compare
v9 2023-01-27 French Compare
v8 2023-01-27 French Compare
v7 2023-01-27 English Compare
v6 2022-12-16 French Compare
v5 2022-12-16 English Compare
v4 2022-12-15 French Compare
v3 2022-12-15 English Compare
v2 2022-12-15 French Compare
v1 2022-12-15 English Compare

Showing 1 to 18 of 18